Reliance Acquires Karkinos Healthcare for ₹375 Crore
In a strategic move to bolster its healthcare portfolio, Reliance Industries, led by Mukesh Ambani, has acquired oncology-focused platform Karkinos Healthcare for ₹375 crore. This acquisition, completed through Reliance Strategic Business Ventures Ltd (RSBVL), is a significant step towards expanding the company’s reach in cancer detection, diagnosis, and treatment.
Deal Structure: Reliance’s subsidiary RSBVL acquired 10 million equity shares and 36.5 million optionally fully convertible debentures of Karkinos for ₹375 crore, with the transaction entirely in cash.
Business Focus: Karkinos, founded in 2020, specializes in providing innovative technology-driven solutions for early cancer detection and management. It has partnered with around 60 hospitals and is setting up a 150-bed cancer hospital in Imphal, Manipur.
Turnover: Karkinos reported a turnover of ₹22 crore in FY 2022-23, with a focus on offering affordable cancer treatments.
Previous Investors: The company’s previous investors included major names like Tata Sons’ subsidiary Ewart Investments, Mayo Clinic, and Reliance Digital Health.
Regulatory Approval: The acquisition followed the approval of Karkinos’ resolution plan under the Insolvency and Bankruptcy Code (IBC) by the National Company Law Tribunal (NCLT), Mumbai Bench, ensuring no additional regulatory hurdles.
Expansion of Healthcare Portfolio: Reliance aims to enhance its healthcare services, particularly oncology, through this acquisition, leveraging Karkinos’ existing infrastructure and partnerships with hospitals.
| Why in News | Key Points |
|---|---|
| Reliance Industries acquires Karkinos Healthcare for ₹375 crore. | – Acquirer: Reliance Strategic Business Ventures Ltd (RSBVL) |
| – Acquisition Amount: ₹375 crore (all-cash deal) | |
| – Karkinos Healthcare: Focus on technology-driven oncology services | |
| – Turnover of Karkinos (2022-23): ₹22 crore | |
| – Acquisition Details: 10 million equity shares and 36.5 million debentures | |
| – NCLT Approval: Approved under Corporate Insolvency Resolution Process (CIRP) | |
| Company Information | – Karkinos Founded: July 24, 2020 |
| – Business Area: Early cancer detection, diagnosis, and treatment | |
| – Investors: Ewart Investments (Tata Sons), Mayo Clinic, Reliance Digital Health | |
| Future Plans | – Cancer Hospital in Imphal: 150-bed multispecialty hospital |
| – Partnerships: 60 hospitals by Dec 2023 | |
| Key Leaders & Figures | – Mukesh Ambani: Chairman, Reliance Industries |
| – Sundar Raman: Director, Reliance Foundation Youth Sports |
The National Zoological Park (NZP), New Delhi has launched the "NZP Saathi App" and Self-ticketing…
India's consumer grievance redressal system has achieved the milestone with the e-Jagriti platform received the…
The sate of West Bengal set to become the 36th State/Union Territory t implement the…
As per the SIPRI Yearbook 2026 India has expanded the its nuclear arsenal to an…
India's Andaman and Nicobar Islands have emerged as the region with lowest fertility rate in…
Every year on 8th of June World Oceans Day observed worldwide. This day raise the…